Literature DB >> 26005805

Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI.

Constantin Lapa1, Theresa Reiter2, Xiang Li3, Rudolf A Werner4, Samuel Samnick3, Roland Jahns5, Andreas K Buck3, Georg Ertl2, Wolfgang R Bauer2.   

Abstract

BACKGROUND: Acute myocarditis as well as post-ischemic myocardial inflammation are generally associated with a profound activation of the immune system. Current established imaging techniques such as cardiac MRI reliably demonstrate signs of acute myocardial injury. However, detection of mediating cells such as macrophages is currently limited to experimental settings. We aimed to investigate the feasibility of somatostatin receptor (SSTR) based positron emission tomography/computed tomography (PET/CT) for detecting inflammatory lesions in patients after acute myocardial infarction or acute peri-/myocarditis.
METHODS: 12 patients with active peri-/myocarditis (n=6) or sub-acute myocardial infarction (n=6) underwent SSTR-PET/CT and cardiac MRI within 3-10 days after onset of symptoms. The AHA 17-segment model of the left myocardium was used for visual localization of inflamed myocardium for both imaging modalities. Tracer uptake of infarcted/inflamed myocardium was assessed as mean and maximum standardized uptake value (SUVmean and SUVmax) and compared with both remote myocardium and left ventricular (LV) cavity.
RESULTS: SSTR-PET/CT revealed areas with increased cardiac tracer uptake in all patients. In the 17-segment model, PET/CT yielded 55 and MRI 47 positive segments. Overall, concordance of the 2 modalities was 85.3% (174/204 segments analyzed). In 9.3% (19/204), more positive segments were identified by PET/CT, whereas in 5.4% (11/204), MRI detected more positive segments.
CONCLUSIONS: The imaging patterns of SSTR-directed radiotracers and MRI in vivo show a close spatial relation of macrophage concentration and structural changes. This suggests the possibility of a new potential biomarker that predicts cardiac remodeling and, hence, progression towards heart failure. Prospective trials are warranted.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Macrophages; Myocardial inflammation; Myocarditis; PET; Somatostatin receptor

Mesh:

Substances:

Year:  2015        PMID: 26005805     DOI: 10.1016/j.ijcard.2015.05.073

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  32 in total

1.  Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis.

Authors:  Paco E Bravo; Amitoj Singh; Marcelo F Di Carli; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2018-11-02       Impact factor: 5.952

Review 2.  PET Assessment of Immune Cell Activity and Therapeutic Monitoring Following Myocardial Infarction.

Authors:  James T Thackeray
Journal:  Curr Cardiol Rep       Date:  2018-03-06       Impact factor: 2.931

Review 3.  The role of positron emission tomography in the assessment of cardiac sarcoidosis.

Authors:  Dario Genovesi; Matteo Bauckneht; Corinna Altini; Cristina Elena Popescu; Paola Ferro; Lavinia Monaco; Anna Borra; Cristina Ferrari; Federico Caobelli
Journal:  Br J Radiol       Date:  2019-06-05       Impact factor: 3.039

Review 4.  Potential novel imaging targets of inflammation in cardiac sarcoidosis.

Authors:  Jakob Park; Bryan D Young; Edward J Miller
Journal:  J Nucl Cardiol       Date:  2021-11-03       Impact factor: 3.872

5.  Molecular Imaging Visualizes Recruitment of Inflammatory Monocytes and Macrophages to the Injured Heart.

Authors:  Gyu Seong Heo; Benjamin Kopecky; Deborah Sultan; Monica Ou; Guoshuai Feng; Geetika Bajpai; Xiaohui Zhang; Hannah Luehmann; Lisa Detering; Yi Su; Florian Leuschner; Christophe Combadière; Daniel Kreisel; Robert J Gropler; Steven L Brody; Yongjian Liu; Kory J Lavine
Journal:  Circ Res       Date:  2019-03-15       Impact factor: 17.367

6.  Emerging imaging targets for infiltrative cardiomyopathy: Inflammation and fibrosis.

Authors:  Frank M Bengel; Tobias L Ross
Journal:  J Nucl Cardiol       Date:  2018-07-02       Impact factor: 5.952

7.  Quantitative 68Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with 177Lu-DOTATATE.

Authors:  Claudia Ortega; Rebecca K S Wong; Josh Schaefferkoetter; Patrick Veit-Haibach; Sten Myrehaug; Rosalyn Juergens; David Laidley; Reut Anconina; Amy Liu; Ur Metser
Journal:  J Nucl Med       Date:  2021-02-12       Impact factor: 10.057

8.  Speckle Tracking Based Strain Analysis Is Sensitive for Early Detection of Pathological Cardiac Hypertrophy.

Authors:  Xiangbo An; Jingjing Wang; Hao Li; Zhizhen Lu; Yan Bai; Han Xiao; Youyi Zhang; Yao Song
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

Review 9.  PET Imaging of Post-infarct Myocardial Inflammation.

Authors:  Andrej Ćorović; Meritxell Nus; Ziad Mallat; James H F Rudd; Jason M Tarkin
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

10.  A dual tracer (68)Ga-DOTANOC PET/CT and (18)F-FDG PET/CT pilot study for detection of cardiac sarcoidosis.

Authors:  Lars C Gormsen; Ate Haraldsen; Stine Kramer; Andre H Dias; Won Yong Kim; Per Borghammer
Journal:  EJNMMI Res       Date:  2016-06-17       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.